Comparison of clinical efficacy of Qingfei Paidu decoction combined with western medicine in 43 cases and single western medicine in 46 cases in the treatment of COVID-19
Journal of Shandong University
; 58(12):47-53, 2020.
Article
in Chinese
| CAB Abstracts | ID: covidwho-1835591
ABSTRACT
Objective:
To retrospectively evaluate the clinical efficacy of Qingfei Paidu decoction in the treatment of coronavirus disease 2019 (COVID-19)and to explore the possible mechanism.
Prion, Viral, Bacterial and Fungal Pathogens of Humans [VV210]; Health Services [UU350]; Non-food/Non-feed Plant Products [SS200]; Pesticides and Drugs; Control [HH405]; Human Immunology and Allergology [VV055]; human diseases; coronavirus disease 2019; C-reactive protein; viral diseases; interleukin 6; patients; blood serum; cell mediated immunity; enzymes; immunity; inflammation; interleukins; kinases; lactate dehydrogenase; renal function; T lymphocytes; traditional Chinese medicine; clinical trials; herbal drugs; hospital stay; neutrophils; creatine kinase; fibrinogen; lymphocytes; CD8+ lymphocytes; CD4+ lymphocytes; creatinine; nucleic acids; pathogens; man; Severe acute respiratory syndrome coronavirus 2; China; Hubei; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; APEC countries; East Asia; Asia; high Human Development Index countries; upper-middle income countries; Central Southern China; SARS-CoV-2; People's Republic of China; viral infections; cellular immunity; Hopei; Hupei; kidney function; T cells; TCM; herbal medicines; creatine phosphokinase; CD8+ cells; T8 lymphocytes; T4 lymphocytes; CD4+ cells
Full text:
Available
Collection:
Databases of international organizations
Database:
CAB Abstracts
Type of study:
Prognostic study
Language:
Chinese
Journal:
Journal of Shandong University
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS